eNauka - pregled

Pregled prema Autor Hoock, Thomas

Prikaz rezultata 1 do 2 od 2
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2015A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid ArthritisFleischmann, Roy M.; Damjanov, Nemanja ; Kivitz, Alan J.; Legedza, Anna; Hoock, Thomas; Kinnman, NilsArticle
21aM21a
2011Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA).Fleischmann, Roy M; Spencer-Green, George T; Fan, Frank; Frankovic, Biliana; Luo, Xia; Hoock, Thomas; Damjanov, Nemanja SConference Paper
Mp. category will be shown later